Biblio Discovery — Demo Discovery Service

17 hasil untuk "Marta Camprubí-Rimblas"

Menampilkan 1–17 · 1,18 detik · RSS

  1. Artikel Jurnal

    Pharmacological inhibition of the CCL2-CCR2 axis fails to reduce inflammation in a rat model of acute lung injury

    Marta Camprubí-Rimblas; Neus Tantinyà; Antonio Artigas dkk.

    Scientific Reports, Vol. 15 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract New therapeutic approaches are needed to regulate inflammation and control monocyte recruitment in acute respiratory distress syndrome (ARDS). Excessive monocyte influx into the alveolar space can exacerbate lung damage, worsening patient outcomes. Delaying or reducing monocyte recruitment…

  2. Artikel Jurnal

    Biomarker-guided use of corticosteroids in pneumonia

    Abel Soriano Puig; Veronica Monforte; Marta Camprubí-Rimblas dkk.

    Pneumonia, Vol. 18 No. 1 · 2026 · Inggris · DOAJ

    Abstract Community-acquired pneumonia (CAP) is one of the leading causes of death worldwide. Although corticosteroids have been proposed as immunomodulatory, controversies surrounding the results of clinical trials have limited their widespread use. This review aims to determine which…

  3. Artikel Jurnal

    The role of hypercapnia in acute respiratory failure

    Luis Morales-Quinteros; Marta Camprubí-Rimblas; Josep Bringué dkk.

    Intensive Care Medicine Experimental, Vol. 7 No. S1 · 2019 · Inggris · DOAJ Scopus

    Abstract The biological effects and physiological consequences of hypercapnia are increasingly understood. The literature on hypercapnia is confusing, and at times contradictory. On the one hand, it may have protective effects through attenuation of pulmonary inflammation and oxidative stress. On…

  4. Artikel Jurnal Teks lengkap

    Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats

    Raquel Guillamat-Prats; Marta Camprubí-Rimblas; Ferranda Puig dkk.

    Cells, Vol. 9 No. 8 · 2020 · Inggris · DOAJ Scopus

    The use of cell therapies has recently increased for the treatment of pulmonary diseases. Mesenchymal stem/stromal cells (MSCs) and alveolar type II cells (ATII) are the main cell-based therapies used for the treatment of acute respiratory distress syndrome (ARDS). Many pre-clinical studies have…

  5. Artikel Jurnal

    Source control within 12 h attenuates lung injury and systemic bacterial burden in a rat model of polymicrobial abdominal sepsis (cecal ligation and puncture)

    Maria Luisa Martinez; Eva Torrents; Marta Camprubí-Rimblas dkk.

    Intensive Care Medicine Experimental, Vol. 14 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Background Early and adequate source control (SC) is a cornerstone of sepsis management, yet experimental data linking delays in SC to bacterial dissemination and remote organ injury remain limited. We aimed to determine how the timing of surgical SC after polymicrobial abdominal sepsis…

  6. Artikel Jurnal

    Bioengineered extracellular vesicles: future of precision medicine for sepsis

    Aina Areny-Balagueró; Anna Solé-Porta; Marta Camprubí-Rimblas dkk.

    Intensive Care Medicine Experimental, Vol. 11 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Sepsis is a syndromic response to infection and is frequently a final common pathway to death from many infectious diseases worldwide. The complexity and high heterogeneity of sepsis hinder the possibility to treat all patients with the same protocol, requiring personalized management. The…

  7. Artikel Jurnal

    ROLE OF MIRNAS SHUTTLED BY LPS-PRIMED MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES IN MODULATING MACROPHAGE ACTIVATION

    Aina Areny-Balagueró; Navneet Purewal-Chohan; Marta Camprubí-Rimblas dkk.

    Open Respiratory Archives, Vol. 8 · 2026 · Spanyol · DOAJ Scopus

    Introduction: Mesenchymal stem cells (MSCs) have regenerative and immunomodulatory properties largely mediated by extracellular vesicles (EVs). Priming MSCs with lipopolysaccharide (LPS) enhances the therapeutic efficacy of their EVs, particularly in acute lung injury. This study investigates the…

  8. Artikel Jurnal Teks lengkap

    Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge

    Aina Areny-Balagueró; Wid Mekseriwattana; Marta Camprubí-Rimblas dkk.

    Pharmaceutics, Vol. 14 No. 7 · 2022 · Inggris · DOAJ Scopus

    Nearly four million yearly deaths can be attributed to respiratory diseases, prompting a huge worldwide health emergency. Additionally, the COVID-19 pandemic’s death toll has surpassed six million, significantly increasing respiratory disease morbidity and mortality rates. Despite recent advances…

  9. Artikel Jurnal

    Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury

    Marta Camprubí–Rimblas; Raquel Guillamat-Prats; Thomas Lebouvier dkk.

    Respiratory Research, Vol. 18 No. 1 · 2017 · Inggris · DOAJ Scopus

    Abstract Background In the early stages of acute respiratory distress syndrome (ARDS), pro-inflammatory mediators inhibit natural anticoagulant factors and initiate an increase in procoagulant activity. Previous studies proved the beneficial effects of heparin in pulmonary coagulopathy, which…

  10. Artikel Jurnal Teks lengkap

    Priming Mesenchymal Stem Cells with Lipopolysaccharide Boosts the Immunomodulatory and Regenerative Activity of Secreted Extracellular Vesicles

    Aina Areny-Balagueró; Marta Camprubí-Rimblas; Elena Campaña-Duel dkk.

    Pharmaceutics, Vol. 16 No. 10 · 2024 · Inggris · DOAJ Scopus

    Background: Mesenchymal stem cells (MSCs)-derived extracellular vesicles (EVs) have been proposed as an alternative to live-cell administration for Acute Respiratory Distress Syndrome (ARDS). MSC-EVs can be chiefly influenced by the environment to which the MSCs are exposed. Here…

  11. Artikel Jurnal

    Efficient Nebulization and Pulmonary Biodistribution of Polymeric Nanocarriers in an Acute Lung Injury Preclinical Model

    Anna Solé‐Porta; Aina Areny‐Balagueró; Marta Camprubí‐Rimblas dkk.

    Small Science, Vol. 4 No. 9 · 2024 · Inggris · DOAJ Scopus

    Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by acute hypoxemic respiratory failure. Pneumonia and sepsis are the most common causes, turning ARDS into a critical public health problem. Despite recent advances in pharmacological strategies, clinical trials have…

  12. Artikel Jurnal

    Hypercapnic acidosis affects in vitro lung infection response in a pathogen-specific manner

    Elena Campaña-Duel; Aina Areny-Balagueró; Luis Morales-Quinteros dkk.

    Frontiers in Cellular and Infection Microbiology, Vol. 15 · 2026 · Inggris · DOAJ Scopus

    BackgroundHypercapnic acidosis (HCA) is a hallmark of acute hypercapnic respiratory failure, often triggered by respiratory infections. Its role in lung injury remains controversial, with both protective and detrimental effects reported. However, the specific impact on pulmonary immune responses to…

  13. Artikel Jurnal

    Point-of-care LPS-induced TNF-α release testing for early sepsis risk stratification in the emergency department

    Berta Cisteró; Adrian Ceccato; Erika P. Plata-Menchaca dkk.

    Frontiers in Immunology, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    Background and objectiveEarly changes in innate immune responsiveness precede overt organ dysfunction in sepsis. In emergency department (ED) patients with suspected infection and physiological deterioration, we estimated the prevalence of reduced LPS-induced TNF-α responsiveness, characterized the…

  14. Artikel Jurnal Teks lengkap

    Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia

    Adrian Ceccato; Marta Camprubí-Rimblas; Lieuwe D. J. Bos dkk.

    Biomedicines, Vol. 11 No. 10 · 2023 · Inggris · DOAJ Scopus

    BACKGROUND: Ventilator-associated pneumonia (VAP) is a severe condition. Early and adequate antibiotic treatment is the most important strategy for improving prognosis. Pancreatic Stone Protein (PSP) has been described as a biomarker that increases values 3–4 days before the clinical diagnosis of…

  15. Artikel Jurnal

    Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia

    Ana Motos; Hua Yang; Gianluigi Li Bassi dkk.

    Critical Care, Vol. 27 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Pseudomonas aeruginosa pneumonia is commonly treated with systemic antibiotics to ensure adequate treatment of multidrug resistant (MDR) bacteria. However, intravenous (IV) antibiotics often achieve suboptimal pulmonary concentrations. We therefore aimed to evaluate the effect…

  16. Artikel Jurnal Teks lengkap

    Early Identification of a Cytokine-Low Immune Phenotype in Suspected Sepsis Using a Point-of-Care Whole-Blood TNF-α Release Assay

    Erika P. Plata-Menchaca; Berta Cisteró; Adrian Ceccato dkk.

    Medical Sciences, Vol. 14 No. 4 · 2026 · Inggris · DOAJ Scopus

    Background/Objectives: Routine biomarkers and clinical scores do not directly assess functional immune responsiveness in suspected sepsis. We evaluated whether the TNF-α Release Assay (TARA), a whole-blood LPS-induced functional assay, is associated with an early cytokine-low immune phenotype in…

  17. Artikel Jurnal

    A long-lasting porcine model of ARDS caused by pneumonia and ventilator-induced lung injury

    Enric Barbeta; Marta Arrieta; Ana Motos dkk.

    Critical Care, Vol. 27 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Animal models of acute respiratory distress syndrome (ARDS) do not completely resemble human ARDS, struggling translational research. We aimed to characterize a porcine model of ARDS induced by pneumonia—the most common risk factor in humans—and analyze the additional effect of…